Real-world evidenceand clinical observations of the treatment of advanced non-small cell lung cancer with PD-1/PD-L1 inhibitors

To summarize the therapeutic effects of PD-1/PD-L1 inhibitors on patients with advanced non-small cell lung cancer (NSCLC) in a real-world setting, we attempted to identify potential molecular biomarkers or clinical factors that reflected the therapeutic effect. The medical records of patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Peng, Zhang, Jingcheng, Shang, Congcong, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414649/
https://www.ncbi.nlm.nih.gov/pubmed/30862891
http://dx.doi.org/10.1038/s41598-019-40748-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414649/
https://www.ncbi.nlm.nih.gov/pubmed/30862891
http://dx.doi.org/10.1038/s41598-019-40748-7

Ejemplares similares